The increase in revenue from our fertility benefits solution and Progyny Rx solution was primarily due to the increase in the number of clients and covered lives, largely offset by the impact of the …
Progyny, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PGNY-DEBT-11755
Warrants outstanding: 22765000
90%
xbrl warrant detail from xbrl 2019-12-31.
PGNY-DEBT-11756
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2019-12-31.
PGNY-DEBT
Debt stack $27.3M
90%
Market cache reports total debt of $27.3M.
Progyny, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Progyny, Inc..
Progyny, Inc. Ownership
Holder
Name
Confidence
Evidence
PGNY-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 296 tracked holders.
Progyny, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.